Clinuvel Pharmaceuticals Statistics

NASDAQ: CUVLMiscellaneousMiscellaneousUSD

5.60-0.20 (-3.45%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 5.58 -0.36%

Clinuvel Pharmaceuticals by the numbers

Clinuvel Pharmaceuticals has a market capitalization of $282.7 million based on 50.49M shares outstanding. Its trailing P/E ratio is 12.4. The stock trades 12.4% below its 50-day average and 20.7% below its 200-day average.

Average daily trading volume is 12.84K shares, or about $71,876 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CUVL valuation vs. peer median

CUVL compared with the median of 3 peer companies
Metric	CUVL	Peer median	Difference
Market cap	$282.73M	$4.35M	+6394%
Avg. volume	12.84K	2.32M	-99%

Peer median across 3 companies: DXST, CDTG, FERG.

Valuation

Market cap: $282.73M
P/E (TTM): 12.44
Forward P/E: —
EPS (TTM): $0.45
Shares outstanding: 50.49M

Price and trading

Previous close: 5.80
Open: 5.57
Day range: 5.53 – 5.60
52-week range: 5.53 – 8.92
52-week change: -29.70%
50-day moving average: 6.39
200-day moving average: 7.06
Beta: —
Volume: 11.95K
Average volume: 12.84K

Dividends and events

Annual dividend: $0.05
Dividend yield: 0.89%
Ex-dividend date: —
Next earnings date: —

Additional statistics

Market Cap: 282.73M
Pe: 12.44
Eps: 0.45
Dividend Yield: 62.00%
Dividend Rate: 0.05
Week52 High: 8.92
Week52 Low: 5.53
Avg Volume: 12,835.00
Shares Outstanding: 50.49M
Ma50: 6.39
Ma200: 7.06
Pct From52w High: -37.22%
Pct From52w Low: 1.36%